Clinical trial

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

NCT07732907

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-06-04

PhaseN/A

Study timeline

Study start (actual)2026-06-04Date precision: day

Registry last updated2026-07-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Progressive Multifocal Leukoencephalopathyunresolved

Interventions

OzanimodDRUG · verified · RxNorm: ozanimod

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07732907 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.